TNFSF10 and cancer: SAHA and TRAIL were demonstrated to possess augmented apoptosis-inducing potential in combination, in an increasing list of human cancer cell lines, such as leukemia [24], prostate cancer [25], breast tumor [26], melanoma [27], Ewing sarcoma [28], and hepatocellular carcinoma [29].